Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Chi make a range of healthy food and drinks including raw coconut water, dairy free coconut milk and coconut oil. Chi is already in over 3,000 UK stores and over 30 countries. They also supply a number of major supermarkets such as Sainsbury's, Tesco, Asda and Waitrose.
days to go:
Expired
investment:
£123,360
StarStock are a drinks marketplace that enable suppliers to sell direct to wholesalers, pubs, shops, bars & restaurants nationwide. StarStock puts the suppliers in control of their products and listings, taking a small percentage of each sale. Suppliers set the prices, while we do the rest, arranging delivery of beers, ciders, wine and spirits.
days to go:
Expired
investment:
£1,343,149
Whey Forward Health make innovative health and nutrition products. Since the launch in 2013 they have sold over 350,000 products. Promixx an original vortex mixer, battery powered, self-stirring protein shake maker, being their first product which is now sold in over 50 countries. They are now looking to launch two new shakes Regenerative and Morning Glory which are repeat purchase products. The investment will create two new websites operating on a subscription model and help them unlock their growth potential.
days to go:
Expired
investment:
£292,399
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go:
Expired
investment:
£136,827
Naturelly is low in calories and rich in vitamin C, designed to be fun, flavorsome and healthy for children. For every pouch sold a percentage is donated to the charity ''hope for children''. They have no added sugar or sweeteners and are suitable for vegans, vegetarians and for sufferers of all top 14 allergens.
days to go:
Expired
investment:
£50,184
Cheran's Bakery, based in Kent, specializes in crafting sumptuous sweet treats available online and at their expanding chain of five stores. With sales exceeding £1.2 million since inception, they create indulgent and creatively packaged products, baked daily for maximum freshness and luxury. Their high-quality, visually appealing shop designs and 'Instagrammable' offerings have attracted over 24,000 social media followers, amplifying brand recognition, while their focus on delivering exceptional customer experiences fosters word-of-mouth promotion.
days to go:
Expired
investment:
£325,482
